Zometa Jaw Bone Death Awareness Program Should Be Enhanced – Cmte.
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's Oncologic Drugs Advisory Committee recommends that distribution of Novartis' "Dear Doctor" letter for Zometa and Aredia be extended to include dentists. Aggressive promotion of the bisphosphonates should also be curtailed, committee members suggest.